NCT07043283 A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjects Status NOT_YET_RECRUITING Phase PHASE1
NCT07023315 A Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma Status RECRUITING Phase PHASE3
NCT07010263 A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy Status RECRUITING Phase PHASE3
NCT06984718 A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC Status NOT_YET_RECRUITING Phase PHASE2
NCT06953999 A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer Status RECRUITING Phase PHASE3
NCT06951646 ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive) Status RECRUITING Phase PHASE2
NCT06951503 AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer Status RECRUITING Phase PHASE3
NCT06943820 AK129 Combination Therapy for Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06938321 A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06929663 A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06928389 Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT06919510 A Phase ll Study of Neoadjuvant Short-course Radiotherapy Followed by Ivonescimab and Chemotherapy in pMMR/MSS Locally Advanced Rectal Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06913218 A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC Status NOT_YET_RECRUITING Phase PHASE1
NCT06860789 AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN) Status NOT_YET_RECRUITING Phase PHASE1
NCT06767540 A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis Status NOT_YET_RECRUITING Phase PHASE3
NCT06767527 AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer Status RECRUITING Phase PHASE3
NCT06756126 A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD) Status NOT_YET_RECRUITING Phase PHASE2
NCT06730386 A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06700499 A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE2